Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Ferzli, George S., M.D. F.A.C.S. |
---|---|
Information provided by: | Ferzli, George S., M.D. F.A.C.S. |
ClinicalTrials.gov Identifier: | NCT00694278 |
The aim of this study and the primary outcome is to clinically evaluate effect of laparoscopic duodenal-jejunal bypass on non-obese type 2 diabetes. Secondary outcomes will evaluate CCK, FFA, Cholesterol Ghrelin, C-peptide, and HbA1c levels. Patients will be followed closely to ensure the desired results are sustained in long term
Study Type: | Observational |
Study Design: | Case-Only, Cross-Sectional |
Official Title: | Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes in Adults |
Ages Eligible for Study: | 20 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
primary care office
Inclusion Criteria:
Clinical diagnosis of type II diabetes buy on of the following three criteria (American Diabetes Association)
Exclusion Criteria:
Contact: George Ferzli, MD | 718-630-7351 | gferzli@lmcmc.com |
United States, New York | |
Lutheran Medical Center | Recruiting |
Brooklyn, New York, United States, 11220 | |
Contact: George Ferzli, MD 718-630-7351 |
Study Chair: | George Ferzli, MD | Lutheran Medical Center |
Responsible Party: | Lutheran Medical Center ( Georger Ferzli M.D F.A.C.S. ) |
Study ID Numbers: | LMC95 |
Study First Received: | June 5, 2008 |
Last Updated: | June 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00694278 |
Health Authority: | United States: Institutional Review Board |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders |